Search

Displaying results 7851 - 7860 of 10000 in total
  1. Drug

    KOS-1584

    go.drugbank.com/drugs/DB05903
    Investigational

    KOS-1584 is a second-generation compound with increased potency, favorable tissue distribution, and ease of formulation.

  2. Drug

    Fluorofuranylnorprogesterone F-18

    go.drugbank.com/drugs/DB15282
    Investigational

    Fluorofuranylnorprogesterone F-18 is under investigation in clinical trial NCT02455453 (Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography).

  3. Drug

    AZD-4877

    go.drugbank.com/drugs/DB11671
    Investigational

    AZD4877 has been used in trials studying the treatment of NHL, Tumors, Cancer, Lymphoma, and Neoplasms, among others.

  4. Drug

    Ruboxistaurin

    go.drugbank.com/drugs/DB11829
    Investigational

    Ruboxistaurin has been investigated for the basic science of Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus.

  5. Drug

    Lucitanib

    go.drugbank.com/drugs/DB11845
    Investigational

    Lucitanib has been used in trials studying the treatment of ER+, MBC, SCLC, HER2+, and NSCLC, among others.

  6. Drug

    Vicagrel

    go.drugbank.com/drugs/DB16349
    Investigational

    Vicagrel is under investigation in clinical trial NCT03599284 (The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel).

  7. Drug

    ENB-003

    go.drugbank.com/drugs/DB17340
    Investigational

    ENB-003 is a selective and potent inhibitor of the endothelin B receptor (ETBR) being investigated for cancer.

  8. Drug

    Nelmastobart

    go.drugbank.com/drugs/DB19000
    Investigational

    Nelmastobart is under investigation in clinical trial NCT05990543 (Combination of Nelmastobart and Capecitabine Therapy in Metastatic Colorectal Cancer).

  9. Drug

    Recaticimab

    go.drugbank.com/drugs/DB19302
    Investigational

    Recaticimab is under investigation in clinical trial NCT06467617 (Adebrelimab Plus Chemo and Recaticimab Perioperative Treatment for Resectable NSCLC).

  10. Drug

    Dihematoporphyrin ether

    go.drugbank.com/drugs/DB15351
    Investigational

    Dihematoporphyrin ether is under investigation in clinical trial NCT00118222 (High Light and Low Light Dose PDT in Glioma).